Jake Heinrichs has been treated in that study for more than a decade and remains symptom-free despite inheriting an Alzheimer’s-causing gene that killed his father and brother around the same ...

Jake Heinrichs sits with his 3-year-old son, Sam, during his infusion treatment with an experimental anti-amyloid Alzheimer's drug in New York, on Wednesday, March 12, 2025. (AP Photo/Heather Khalifa) ...

Jake Heinrichs has been treated in that study for more than a decade and remains symptom-free despite inheriting an Alzheimer’s-causing gene that killed his father and brother around the same age.

Jake Heinrichs sits with his 3-year-old son, Sam, during his infusion treatment with an experimental anti-amyloid Alzheimer's drug in New York, on Wednesday, March 12, 2025. (AP Photo/Heather Khalifa) ...

Jake Heinrichs sits with his 3-year-old son, Sam, during his infusion treatment with an experimental anti-amyloid Alzheimer’s drug in New York, on Wednesday, March 12, 2025.

Jake Heinrichs prepares for his infusion treatment with an experimental anti-amyloid Alzheimer's drug while at home in New York, on Wednesday, March 12, 2025.

Jake Heinrichs watches television with his 3-year-old son, Sam, while his wife, Rachel Chavkin, works during his infusion treatment with an experimental anti-amyloid Alzheimer's drug in New York ...

“It’s still a study but it has given me an extension to my life that I never banked on having,” said Jake Heinrichs of New York City. Now 50, Heinrichs has been treated in that study for ...

Jake Heinrichs sits with his 3-year-old son, Sam, during his infusion treatment with an experimental anti-amyloid Alzheimer's drug in New York, on Wednesday, March 12, 2025. (AP Photo/Heather Khalifa) ...

Jake Heinrichs plays with his 3-year-old son, Sam, after his infusion treatment with an experimental anti-amyloid Alzheimer’s drug in New York, on Wednesday, March 12, 2025.